Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.7 / 5 stars · 19/56 Roast Me

VISTAGEN THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

VISTAGEN THERAPEUTICS, INC. (VTGN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 25.81 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14

  • VISTAGEN THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 25.81M shares, a 2.02% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 25.30M shares, a 7.72% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 23.48M shares, a 2997.21% increase year-over-year.
  • VISTAGEN THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-06-30 was 758.24K shares, a 21.57% decline year-over-year.
  • VISTAGEN THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2026 was 25.02M shares, a 5.06% increase from fiscal 2025.
  • VISTAGEN THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 23.81M shares, a 11.16% increase from fiscal 2024.
  • VISTAGEN THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 21.42M shares, a 2762.78% increase from fiscal 2023.
  • VISTAGEN THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 748.23K shares, a 21.68% decline from fiscal 2022.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-3025.81M shares
10-Q · filed 2026-08-14
2026-03-3125.02M shares
10-K · filed 2026-06-15
2025-12-3125.42M shares
10-Q · filed 2026-02-12
2025-09-3025.43M shares
10-Q · filed 2025-11-13
2025-06-3025.30M shares
10-Q · filed 2026-08-14
2025-03-3123.81M shares
10-K · filed 2026-06-15
2024-12-3123.69M shares
10-Q · filed 2026-02-12
2024-09-3023.72M shares
10-Q · filed 2025-11-13
2024-06-3023.48M shares
10-Q · filed 2025-08-07
2024-03-3121.42M shares
10-K · filed 2025-06-17
2023-12-3121.33M shares
10-Q · filed 2025-02-13
2023-09-30770.24K shares
10-Q · filed 2024-11-07
2023-06-30758.24K shares
10-Q · filed 2024-08-13
2023-03-31748.23K shares
10-K · filed 2024-06-11
2022-12-31832.18K shares
10-Q · filed 2024-02-13		24.97M shares
10-Q · filed 2023-02-07
2022-09-30973.71K shares
10-Q · filed 2023-11-09		29.21M shares
10-Q · filed 2022-11-10
2022-06-30966.81K shares
10-Q · filed 2023-08-10		29.00M shares
10-Q · filed 2022-08-11
2022-03-31955.41K shares
10-K · filed 2023-06-28		28.66M shares
10-K · filed 2022-06-23
2021-12-3125.21M shares
10-Q · filed 2023-02-07
2021-09-3031.52M shares
10-Q · filed 2022-11-10
2021-06-3034.41M shares
10-Q · filed 2022-08-11
2021-03-3147.45M shares
10-K · filed 2022-06-23		38.60M shares
10-K · filed 2021-06-29
2020-12-3188.23M shares
10-Q · filed 2021-02-11
2020-09-3042.06M shares
10-Q · filed 2020-11-12
2020-06-3042.77M shares
10-Q · filed 2020-08-13
2020-03-3147.45M shares
10-Q · filed 2021-08-12		40.79M shares
10-K · filed 2020-06-29
2019-12-3137.21M shares
10-Q · filed 2020-02-13
2019-09-3040.79M shares
10-Q · filed 2020-11-12		33.49M shares
10-Q · filed 2019-11-07
2019-06-3040.79M shares
10-Q · filed 2020-08-13		33.53M shares
10-Q · filed 2019-08-13
2019-03-3132.31M shares
10-K · filed 2020-06-29
2018-12-3132.14M shares
10-Q · filed 2020-02-13
2018-09-3031.10M shares
10-Q · filed 2019-11-07
2018-06-3026.17M shares
10-Q · filed 2019-08-13
2018-03-3126.13M shares
10-K · filed 2019-06-25
2017-12-3124.43M shares
10-Q · filed 2019-02-12
2017-09-3014.47M shares
10-Q · filed 2018-10-29
2017-06-3011.55M shares
10-Q · filed 2018-08-14
2017-03-3110.47M shares
10-K · filed 2018-06-26
2016-12-3110.44M shares
10-Q · filed 2018-02-12
2016-09-3010.01M shares
10-Q · filed 2017-11-09
2016-06-309.91M shares
10-Q · filed 2017-08-14
2016-03-318.98M shares
10-K · filed 2017-06-29
2015-12-3110.14M shares
10-Q · filed 2017-02-13
2015-09-309.70M shares
10-Q · filed 2016-11-14
2015-06-308.22M shares
10-Q · filed 2016-08-12
2015-03-313.76M shares
10-K · filed 2016-06-24
2014-12-313.09M shares
10-Q · filed 2015-02-17		3.09M shares
10-Q · filed 2016-02-16
2014-09-303.00M shares
10-Q · filed 2015-11-16
2014-03-31474.00 shares
10-K · filed 2015-06-29
2013-12-312.59M shares
10-Q · filed 2015-02-17
2013-06-30389.25K shares
10-Q · filed 2013-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Advertisement